Endocrinology
A broad family of tests to help narrow down diagnosis
With a history of expertise in endocrine diagnostics, we can help you identify the right combination of tests to help you better navigate the diagnostic subtleties of an endocrine disorder. With a more holistic picture of your pediatric patient’s condition, you'll be able to make more informed decisions faster and with greater confidence.
Cost-effective and efficient therapeutic monitoring
Monitoring growth hormone therapy in pediatric patients begins with accurate testing. Our high- resolution accurate mass (HRAM-MS) assay can eliminate the need to perform genetic tests to ensure accurate measurement of insulin-like growth factor 1 (IGF-1).
Leveraging expertise to simplify the diagnostic journey
We combine diagnostic leadership and clinical expertise to create and offer an extensive menu of routine panels that address common pediatric conditions. Our approach is exclusively focused on helping you deliver better outcomes for your patients.
News and updates
The latest
Learn more about how Mayo Clinic Laboratories first-in-class insulin analogs assay uses liquid chromatography-high resolution mass spectrometry to provide clinicians with a highly specific way to identify and differentiate human insulin from multiple synthetic insulin analogs from a single blood sample. By overcoming the limitations of traditional immunoassays, the test delivers greater diagnostic clarity in complex hypoglycemia cases, helping clinicians reach accurate diagnoses faster and guide more effective patient care.
Learn more about how Mayo Clinic Laboratories first-in-class insulin analogs assay uses liquid chromatography-high resolution mass spectrometry to provide clinicians with a highly specific way to identify and differentiate human insulin from multiple synthetic insulin analogs from a single blood sample. By overcoming the limitations of traditional immunoassays, the test delivers greater diagnostic clarity in complex hypoglycemia cases, helping clinicians reach accurate diagnoses faster and guide more effective patient care.
Understanding the difference between benign and malignant adrenal tumors has always been difficult, but the new Urinary Steroid Profile assay will assist with this medical challenge.